Revolutionary Electronic Implant Restores Functional Vision in Advanced AMD Patients

Medical researchers have announced a breakthrough in the treatment of advanced dry age-related macular degeneration (AMD), a leading cause of blindness worldwide. A tiny electronic implant paired with special glasses has enabled 27 (84 per cent) of 32 patients to regain functional vision, including the ability to read letters, numbers, and words. This milestone marks a significant advancement in the field, as previous attempts at prosthetic vision resulted only in light perception, not form vision.

Key Takeaways:

• The implant, developed by Daniel Palanker and José-Alain Sahel, bypasses dead light-sensitive cells by converting light into electrical signals transmitted to the brain.
• The procedure involves implanting a 2mm x 2mm microchip under the centre of the retina, which is activated a month later to send signals to the brain.
• Patients undergo training to learn to focus, zoom, and read again, with some achieving acuity equivalent to 20/42 vision with digital enhancements.
• The trial, led by Frank Holz of the University of Bonn, included participants from the UK, France, Italy, and the Netherlands, with 19 experiencing temporary side effects, including ocular hypertension and sub-retinal bleeding.
• The device provides only black-and-white vision currently, but developers are working on software for grayscale and higher resolution.
• The global impact of AMD, affecting over five million people worldwide, highlights the significant potential of this breakthrough technology.

Statistics:

• 27 (84 per cent) of 32 patients regained functional vision with the implant.
• The implant is 2mm x 2mm in size, about half the thickness of a human hair.
• Patients underwent training to learn to focus, zoom, and read again, with some achieving acuity equivalent to 20/42 vision with digital enhancements.
• 19 patients experienced temporary side effects, including ocular hypertension and sub-retinal bleeding.
• All side effects were resolved within two months with no life-threatening events.

Sources:

• "Breakthrough Implant Restores Vision in People with Advanced Macular Degeneration." New England Journal of Medicine, cited in the Stanford University media release.
• Palanker Lab / Stanford Medicine. "Simulation of a patient's vision with macular degeneration." and "Simulation of a patient's vision enhanced with the implant."
• University College London (UCL) Institute of Ophthalmology, UK. "Blind patients regain central vision with revolutionary implant."